Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316277 · ClinicalTrials.gov registry record · Phase 3
Prescription Opioid Addiction Treatment Study (POATS)
A Phase 3 study, sponsored by Mclean Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 653
- Enrollment target
NCT00316277 is a Phase 3 study that has completed, run by Mclean Hospital. The registered enrollment target is 653 participants.
The verdict
NCT00316277, a Phase 3 study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 653 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether treatment outcome for subjects dependent on prescription opioid analgesics can be improved by adding individual drug counseling to the prescription of buprenorphine/naloxone with standard medical management. This will be examined during: a) an initial four-week treatment with taper; b) a 12-week stabilization treatment for those who do not respond successfully to the initial treatment; and c) a long-term follow-up assessment at 1.5 years, 2.5 years, and 3.5 years after treatment.
Interventions
- BEHAVIORAL Standard Medical Management (SMM) of Prescription Opiate Abuse
- BEHAVIORAL Enhanced Medical Management (EMM) of Prescription Opiate Abuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 653 participants |
| Start Date | 2006-05 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00316277
The ClinicalTrials.gov registry entry for NCT00316277 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 653 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Medical Management (SMM) of Prescription Opiate Abuse is the first listed.
NCT00316277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00316277 about?
NCT00316277 is a clinical study titled "Prescription Opioid Addiction Treatment Study (POATS)". The purpose of this study is to determine whether treatment outcome for subjects dependent on prescription opioid analgesics can be improved by adding individual drug counseling to the prescription of buprenorphine/naloxone with standard medical management. This will be examined during: a) an initia...
What is the current status of trial NCT00316277?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 653 participants. The study started on 2006-05. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00316277?
The interventions under investigation include: Standard Medical Management (SMM) of Prescription Opiate Abuse (BEHAVIORAL), Enhanced Medical Management (EMM) of Prescription Opiate Abuse (BEHAVIORAL).
Who is sponsoring clinical trial NCT00316277?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.